Induced pluripotent stem cells in hematology: Current and future applications

D. Focosi; G. Amabile; A. Di Ruscio; P. Quaranta; D. G. Tenen; M. Pistello

doi:10.1038/bcj.2014.30

Induced pluripotent stem cells in hematology: Current and future applications

D. Focosi, G. Amabile, A. Di Ruscio, P. Quaranta, D. G. Tenen, M. Pistello

Risultato della ricerca: Contributo su rivista › Articolo di review › peer review

Abstract

Reprogramming somatic cells into induced pluripotent stem (iPS) cells is nowadays approaching effectiveness and clinical grade. Potential uses of this technology include predictive toxicology, drug screening, pathogenetic studies and transplantation. Here, we review the basis of current iPS cell technology and potential applications in hematology, ranging from disease modeling of congenital and acquired hemopathies to hematopoietic stem and other blood cell transplantation.

Lingua originale	Inglese
Numero di articolo	211
Rivista	Blood Cancer Journal
Volume	4
Numero di pubblicazione	5
DOI	https://doi.org/10.1038/bcj.2014.30
Stato di pubblicazione	Pubblicato - mag 2014
Pubblicato esternamente	Sì

Accesso al documento

10.1038/bcj.2014.30

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{0284aaf79cec4bdc987ac40ae6616f8d,

title = "Induced pluripotent stem cells in hematology: Current and future applications",

abstract = "Reprogramming somatic cells into induced pluripotent stem (iPS) cells is nowadays approaching effectiveness and clinical grade. Potential uses of this technology include predictive toxicology, drug screening, pathogenetic studies and transplantation. Here, we review the basis of current iPS cell technology and potential applications in hematology, ranging from disease modeling of congenital and acquired hemopathies to hematopoietic stem and other blood cell transplantation.",

author = "D. Focosi and G. Amabile and {Di Ruscio}, A. and P. Quaranta and Tenen, {D. G.} and M. Pistello",

note = "Funding Information: We are grateful to the Italian Society of Hematology (SIE) and the Italian League against Leukemia (AIL) for supporting funds. GA was supported by the American Italian Cancer Foundation during this work.",

year = "2014",

month = may,

doi = "10.1038/bcj.2014.30",

language = "English",

volume = "4",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Induced pluripotent stem cells in hematology

T2 - Current and future applications

AU - Focosi, D.

AU - Amabile, G.

AU - Di Ruscio, A.

AU - Quaranta, P.

AU - Tenen, D. G.

AU - Pistello, M.

N1 - Funding Information: We are grateful to the Italian Society of Hematology (SIE) and the Italian League against Leukemia (AIL) for supporting funds. GA was supported by the American Italian Cancer Foundation during this work.

PY - 2014/5

Y1 - 2014/5

N2 - Reprogramming somatic cells into induced pluripotent stem (iPS) cells is nowadays approaching effectiveness and clinical grade. Potential uses of this technology include predictive toxicology, drug screening, pathogenetic studies and transplantation. Here, we review the basis of current iPS cell technology and potential applications in hematology, ranging from disease modeling of congenital and acquired hemopathies to hematopoietic stem and other blood cell transplantation.

AB - Reprogramming somatic cells into induced pluripotent stem (iPS) cells is nowadays approaching effectiveness and clinical grade. Potential uses of this technology include predictive toxicology, drug screening, pathogenetic studies and transplantation. Here, we review the basis of current iPS cell technology and potential applications in hematology, ranging from disease modeling of congenital and acquired hemopathies to hematopoietic stem and other blood cell transplantation.

UR - http://www.scopus.com/inward/record.url?scp=84901982591&partnerID=8YFLogxK

U2 - 10.1038/bcj.2014.30

DO - 10.1038/bcj.2014.30

M3 - Review article

SN - 2044-5385

VL - 4

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 5

M1 - 211

ER -

Induced pluripotent stem cells in hematology: Current and future applications

Abstract

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo